drugset
drugset / Trial / NCT05797922

To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers

NCT05797922 ↗

Phase 1 Unknown 32 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelBasic science

Summary

This study aims to evaluate the effect of food on the pharmacokinetics and safety of DWP16001 after oral administration.

Timeline

Start
2023-03-09
Primary completion
2023-05-31
Completion
2023-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Enavogliflozin Small molecule 0.3 mg Oral

Indications

No indication recorded.